U.S., May 10 -- ClinicalTrials.gov registry received information related to the study (NCT06963307) titled 'Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer' on April 30.
Brief Summary: This trial is a multicenter, open-label, non-interventional controlled study to identify and characterize epigenetic signatures of lung cancer. The goal of this study is to develop a simple blood test that can detect lung cancer with high sensitivity, and assist in the early diagnosis and management of lung cancer.
In particular, the ability to assist existing methods in cancer diagnostics, predict response to treatment, and assess the success of treatment during and after treatment will be examined. In addition, the ability to as...